Literature DB >> 20374731

GPR56 and its related diseases.

Zhaohui Jin1, Rong Luo, Xianhua Piao.   

Abstract

GPR56, an orphan G protein-coupled receptor (GPCR), was identified one decade ago by two independent groups through a degenerate PCR-based approach for secretin-like GPCRs and by differential display of melanoma cell lines with different metastatic potentials. The finding that GPR56 was significantly downregulated in high metastatic melanoma cell lines suggests its possible role in cancer metastasis. However, the function of GPR56 remained unclear until 2004 when mutations in the human GPR56 gene were found to cause a specific brain malformation called bilateral frontoparietal polymicrogyria. Although GPR56 is expressed in a wide range of tissues, the consequences of loss-of-function mutations in the GPR56 gene have only been observed in the central nervous system. Studies from knockout mouse model indicate that GPR56 regulates brain development by affecting the integrity of the pial basement membrane in the developing brain.
Copyright © 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20374731     DOI: 10.1016/S1877-1173(09)89001-7

Source DB:  PubMed          Journal:  Prog Mol Biol Transl Sci        ISSN: 1877-1173            Impact factor:   3.622


  10 in total

Review 1.  G protein-coupled receptors: novel targets for drug discovery in cancer.

Authors:  Rosamaria Lappano; Marcello Maggiolini
Journal:  Nat Rev Drug Discov       Date:  2011-01       Impact factor: 84.694

Review 2.  GPCRs and cancer.

Authors:  Rosamaria Lappano; Marcello Maggiolini
Journal:  Acta Pharmacol Sin       Date:  2012-01-23       Impact factor: 6.150

Review 3.  Chaperoning G protein-coupled receptors: from cell biology to therapeutics.

Authors:  Ya-Xiong Tao; P Michael Conn
Journal:  Endocr Rev       Date:  2014-03-24       Impact factor: 19.871

4.  Characterization of G protein-coupled receptor 56 protein expression in the mouse developing neocortex.

Authors:  Sung-Jin Jeong; Rong Luo; Shihong Li; Natalie Strokes; Xianhua Piao
Journal:  J Comp Neurol       Date:  2012-09-01       Impact factor: 3.215

5.  Disease-associated mutations prevent GPR56-collagen III interaction.

Authors:  Rong Luo; Zhaohui Jin; Yiyu Deng; Natalie Strokes; Xianhua Piao
Journal:  PLoS One       Date:  2012-01-04       Impact factor: 3.240

6.  The adhesion GPCR Gpr56 regulates oligodendrocyte development via interactions with Gα12/13 and RhoA.

Authors:  Sarah D Ackerman; Cynthia Garcia; Xianhua Piao; David H Gutmann; Kelly R Monk
Journal:  Nat Commun       Date:  2015-01-21       Impact factor: 14.919

7.  PAR1 Scaffolds TGFβRII to Downregulate TGF-β Signaling and Activate ESC Differentiation to Endothelial Cells.

Authors:  Haixia Gong; Shejuan An; Antonia Sassmann; Menglin Liu; Victoria Mastej; Manish Mittal; Wei Zhang; Zhigang Hong; Stefan Offermanns; Jalees Rehman; Asrar B Malik
Journal:  Stem Cell Reports       Date:  2016-11-17       Impact factor: 7.765

Review 8.  The role of GPR56/ADGRG1 in health and disease.

Authors:  Abhishek Kumar Singh; Hsi-Hsien Lin
Journal:  Biomed J       Date:  2021-05-04       Impact factor: 4.910

9.  An Integrated Pan-Cancer Analysis and Structure-Based Virtual Screening of GPR15.

Authors:  Yanjing Wang; Xiangeng Wang; Yi Xiong; Cheng-Dong Li; Qin Xu; Lu Shen; Aman Chandra Kaushik; Dong-Qing Wei
Journal:  Int J Mol Sci       Date:  2019-12-10       Impact factor: 5.923

10.  ADGRG1 Is a Predictor of Chemoresistance and Poor Survival in Cervical Squamous Carcinoma.

Authors:  Shuo Zhang; Kui Guo; Ying Liang; Kun Wang; Shuyan Liu; Xingsheng Yang
Journal:  Front Oncol       Date:  2021-07-22       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.